Legislative/Regulatory
The Delaware Healthcare Association comments on a number of health care-related legistive & regulatory issues on behalf of its member hospitals and health systems.
Delaware Health Leaders Issue Joint Letter to Highmark
DHA Comments Board of Pharmacy (SB 180)
Joint Letter – HB 153
Joint Letter – Support of House Bill 215
DHA Supporting Comments Overpayment Recovery and Audit Practice (HB 212)
DHA Comments Respiratory Care Practitioners (SB 94)
DHA Supports Pre-Authorization Reform (SB 12)
DHA Comments Diabetes Wellness Pilot Program (HS 1 for HB 163)
DHA Supporting Comments for Healthcare Services Protections (HB 205)
DHA Supporting Comments Voluntary Admissions (SB 152)
DHA Letter to U.S. Senate on HR 1
Joint Advocate Letter: HB 350 Delay
No results found.